Cardlytics(US:CDLX) ZACKS·2025-05-07 23:51Group 1 - Cardlytics reported a quarterly loss of $0.21 per share, better than the Zacks Consensus Estimate of a loss of $0.27, and compared to a loss of $0.09 per share a year ago, indicating an earnings surprise of 22.22% [1] - The company posted revenues of $61.9 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 7.46%, although this represents a decline from year-ago revenues of $67.61 million [2] - Cardlytics shares have declined approximately 42.1% since the beginning of the year, contrasting with the S&P 500's decline of 4.7% [3] Group 2 - The earnings outlook for Cardlytics is crucial for investors, as it includes current consensus earnings expectations for upcoming quarters and any recent changes to these expectations [4] - The trend for estimate revisions for Cardlytics is currently favorable, leading to a Zacks Rank 2 (Buy) for the stock, suggesting it is expected to outperform the market in the near future [6] - The current consensus EPS estimate for the upcoming quarter is -$0.16 on revenues of $67.9 million, and -$0.58 on revenues of $274.9 million for the current fiscal year [7] Group 3 - The Technology Services industry, to which Cardlytics belongs, is currently ranked in the top 26% of over 250 Zacks industries, indicating a favorable outlook for stocks within this sector [8] - Another company in the same industry, Inspired Entertainment, is expected to report a quarterly loss of $0.14 per share, reflecting a significant year-over-year change of -600% [9]